Korobelnik, Jean-François
Loewenstein, Anat
Eldem, Bora
Joussen, Antonia M.
Koh, Adrian
Lambrou, George N.
Lanzetta, Paolo
Li, Xiaoxin
Lövestam-Adrian, Monica
Navarro, Rafael
Okada, Annabelle A.
Pearce, Ian
Rodríguez, Francisco J.
Wong, David T.
Wu, Lihteh
Funding for this research was provided by:
Bayer Consumer Care AG
Article History
Received: 7 April 2020
Revised: 10 April 2020
Accepted: 13 April 2020
First Online: 23 April 2020
Change Date: 4 November 2022
Change Type: Update
Change Details: Missing URL in reference 2 has been updated.
Compliance with ethical standards
:
: Jean-François Korobelnik is a consultant for Allergan, Bayer, Kanghong, Novartis, and Roche.Anat Loewenstein is a consultant for Allergan, Bayer, Kanghong, Novartis, Roche, ForSight Labs, and Notal Vision.Bora Eldem is a consultant for Bayer, Novartis, and Allergan.Antonia M. Joussen has received research grants from Novartis and Bayer and is a consultant for Allergan, Bayer, Novartis, and Roche.Adrian Koh is a consultant and advisor for Bayer, Novartis, Allergan, Carl Zeiss, Heidelberg, and Topcon.George N. Lambrou is an employee of Bayer AG Pharmaceuticals.Paolo Lanzetta is a consultant for Allergan, Bayer, CenterVue, Novartis, and Roche.Xiaoxin Li is a consultant/advisor for Bayer and has received research funding from Bayer.Monica Lövestam-Adrian has received research grants from Novartis and Bayer and is a consultant for Bayer, Novartis, Allergan, and Santen.Rafael Navarro has received consultancy fees from Allergan and Bayer.Annabelle A. Okada has received research grants from Alcon Pharma KK (Japan), Bayer Yakuhin Ltd. (Japan), Mitsubishi Tanabe Pharma Corporation (Japan), Novartis Pharma KK (Japan), and Santen Pharmaceutical Co. Ltd. (Japan); and personal fees from AbbVie Japan Inc., Alcon Pharma KK (Japan), Allergan Japan, Astellas Japan, Bayer Healthcare AG, Bayer Yakuhin Ltd. (Japan), Chugai Pharmaceutical Co. (Japan), Daiichi-Sankyo, Mitsubishi Tanabe Pharma Corporation (Japan), Novartis Pharma (Japan), Otsuka Pharmaceutical Co. Ltd. (Japan), Senju Pharmaceutical Co. Ltd. (Japan), and Santen Pharmaceutical Co. Ltd. (Japan).Ian Pearce has received consultancy fees/travel/speaker fees from Allergan, Bayer, Novartis, and Roche.Francisco J. Rodríguez is a consultant/member of the speaker bureau for Bayer, Novartis, and Allergan.David T. Wong has received grants/research support from Bayer, Novartis, and Roche, and consulting fees from Alcon, Allergan, Bausch Health, Bayer, Novartis, Topcon, Zeiss, and has minor equity in Arctic DX<b>.</b>Lihteh Wu is a consultant/member of the speaker bureau for Bayer and Quantel Medical.
: This article does not contain any studies with human participants or animals performed by any of the authors. Therefore, informed consent was not required for this analysis.